Abstract

Commercializing scientific research or a breakthrough idea is really no different, in principle, from commercializing anything, except perhaps that it's more difficult in practice because of the steps required to turn basic research into something practical and because you are looking for a market for a product, rather than designing a product to fit an established, or obvious market. Commercialization is different to starting and running a company, a broader endeavour and the subject of a previous Ten Simple Rules article [1]. Even so, commercialization can be a broad endeavour. For example, at one extreme, you could hand over your monoclonal antibody to Sigma to supply it on your behalf to other researchers who might find it useful while the company pays you a small royalty; on the other, you could be involved in developing Herceptin (anti-HER2 monoclonal antibody) from its origins as a mouse-specific antibody through to its use as an effective anti-breast cancer drug, in a process that took more than decade. Here we assume the former—others are carrying out that commercialization, which has its pluses and minuses—less work for you, but typically less control of the commercialization process. Commercialization is a much studied subject, both by academics [2] and the business community [3]. All larger academic institutions generally have offices to promote and help scientists get research to market. Consequently, in this Ten Simple Rules article we won't deal with the details, but instead will concentrate on some of the key issues to consider when working with, or before and after working with, a specialized office.

Highlights

  • Commercialization is different to starting and running a company, a broader endeavour and the subject of a previous Ten Simple Rules article [1]

  • At one extreme, you could hand over your monoclonal antibody to Sigma to supply it on your behalf to other researchers who might find it useful while the company pays you a small royalty; on the other, you could be involved in developing Herceptin from its origins as a mouse-specific antibody through to its use as an effective antibreast cancer drug, in a process that took more than decade

  • The artists understood symbolism; Europeans sought realism. It is with commercialization: scientists are not primed for business and businesses are not, for the most part, so good at science unless they have specialized research divisions—Bell Labs comes to mind here, these days an exception rather than a rule

Read more

Summary

Introduction

Commercialization is different to starting and running a company, a broader endeavour and the subject of a previous Ten Simple Rules article [1]. Commercialization is a much studied subject, both by academics [2] and the business community [3]. All larger academic institutions generally have offices to promote and help scientists get research to market.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.